p53 Sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1202-1209

  Liu, Lin ^a   Scolnick, Daniel M ^a   Trievel, Raymond C ^a   Zhang, Hong Bing ^a   Marmorstein, Ronen ^a   Halazonetis, Thanos D ^a   Berger, Shelley L ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

ACETYLATION; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; DNA BINDING; DNA DAMAGE; DNA SEQUENCE; ELECTROPHORESIS; GENE EXPRESSION; IMMUNOPRECIPITATION; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0032906633     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.2.1202     Document Type: Article

References (66)

1. Anderson, C. Personal communication.
2. Arany, Z., W. R. Sellers, D. M. Livingston, and R. Eckner. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
3. Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229.
4. Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184.
5. Bannister, A., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
6. Bannister, A. J., and T. Kouzarides. 1995. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14:4758-4762.
7. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. Mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
8. Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives. 1993. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:2565-2574.
9. Barlev, N., R. Candau, L. Wang, P. Darpino, N. Silverman, and S. Berger. 1995. Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATA-binding protein. J. Biol. Chem. 270:19337-19344.
10. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. Livingston, 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344-347.
11. Brownell, J., J. Zhou, T. Ranalli, R. Kobayashi, D. Edmondson, S. Roth, and C. D. Allis. 1996. Tetrahymena histone acetyltransferase A: a transcriptional co-activator linking gene expression to histone acetylation. Cell 84:843-851.
12. Buckbinder, L., R Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B. R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649.
13. Candau, R., D. M. Scolnick, P. Darpino, C. Y. Ying, T. Halazonetis, and S. L. Berger. 1997. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15:807-816.
14. Candau, R., J. Zhou, C. D. Allis, and S. L. Berger. 1997. Historic acetyl-transferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J. 16:555-565.
15. Clore, G. M., J. G. Omichinski, K. Sakaguchi, N. Zambrano, H. Sakamoto, E. Appella, and A. M. Gronenborn. 1994. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science 265:386-391.
16. Dai, P., H. Akimaru, Y. Tanaka, D. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, and S. Ishii. 1996. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10:528-540.
17. el Deiry, W., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
18. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
19. Fiscella, M., S. J. Ullrich, N. Zambrano, M. T. Shields, D. Lin, S. P. Lees-Miller, C. W. Anderson, W. E. Mercer, and E. Appella. 1993. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8:1519-1528.
20. Fiscella, M., N. Zambrano, S. J. Ullrich, T. Unger, D. Lin, B. Cho, W. E. Mercer, C. W. Anderson, and E. Appella. 1994. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 9:3249-3257.
21. Funk, W. D., D. T. Pak, R. H. Karas, W. E. Wright, and J. W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866-2871.
22. Gottlieb, T., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102.
23. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
24. Gu, W., X. L. Shi, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819-823.
25. Halazonetis, T. D., L. J. Davis, and A. N. Kandil. 1993. Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA. EMBO J. 12:1021-1028.
26. Halazonetis, T. D., and A. N. Kandil. 1993. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12:5057-5064.
27. Hupp, T., D. Meek, C. Midgley, and D. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
28. Imhof, A., X. Yang, V. Ogryzko, Y. Nakatani, A. Wolffe, and H. Ge. 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:689-692.
29. Jeffrey, P. D., S. Gorina, and N. P. Pavletich. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267:1498-1502.
30. Kapoor, M., and G. Lozano. 1998. Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. USA 95:2834-2837.
31. Kastan, M. B., Q. Zhan, W. et Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
32. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
33. Korzus, E., J. Torchia, D. Rose, L. Xu, R. Kurokawa, E. McInerney, T. Mullen, C. Glass, and M. Rosenfeld. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-707.
34. Kuo, M.-H., J. E. Brownell, T. A. Ranalli, R. G. Cook, D. G. Edmonson, S. Y. Roth, and C. D. Allis. 1996. Transcription-linked acetylation by Gen5p of histones H3 and H4 at specific lysines. Nature 383:269-272.
35. Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226.
36. Lee, W., T. S. Harvey, Y. Yin, P. Yau, D. Utchfield, and C. H. Arrowsmith. 1994. Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1:877-890.
37. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
38. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
39. Luger, K., A. Mader, R. Richmond, D. Sargent, and T. Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251-260.
40. Lundblad, J., R. Kwok, M. Laurance, M. Harter, and R. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional coactivator CBP. Nature 374:85-88.
41. Maltzman, W., and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689-1694.
42. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
43. Mizzen, C., and C. Allis. 1998. Linking histone acetylation to transcriptional regulation. Cell. Mol. Life Sci. 54:6-20.
44. Muller-Tiemann, B., T. Halazonetis, and J. Elting. 1998. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc. Natl. Acad. Sci. USA 95:6079-6084.
45. Oelgeschlager, M., R. Janknecht, J. Krieg, S. Schreek, and B. Luscher. 1996. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperatively with NF-M. EMBO J. 15; 2771-2780.
46. Ogryzko, V., T. Kotani, X. Zhang, R. Schlitz, T. Howard, X. Yang, B. Howard, J. Qin, and Y. Nakatani. 1998. Histone-like TAFs within the PCAF histone acetylase complex. Cell 94:35-44.
47. Ogryzko, V., R. Schlitz, V. Russanova, B. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acctyltransferases. Cell 87:953-959.
48. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
49. Pietenpol, J. A., T. Tokino, S. Thiagalingam, W. el Deiry, K. W. Kinzler, and B. Vogelstein. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91:1998-2002.
50. Puri, P. L., V. Sartorelli, X. J. Yang, Y. Hamamori, V. V. Ogryzko, B. H. Howard, L. Kedes, J. Y. Wang, A. Graessmann, Y. Nakatani, and M. Levrero. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell. 1:35-45.
51. Raycroft, L., H. Y. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
52. Sakamoto, H., M. S. Lewis, H. Kodama, E. Apella, and K. Sakaguchi. 1994. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc. Natl. Acad. Sci. USA 91:8974-8978.
53. Scharer, E., and R. Iggo. 1992. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20:1539-1545.
54. Scolnick, D., N. Chehab, E. Stavridi, M. Lien, L. Caruso, E. Moran, S. Berger, and T. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:3693-3696.
55. Scolnick, D. M., and L. Liu. Unpublished data.
56. Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition hy MDM2. Cell 91:325-334.
57. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599-606.
58. Sturzbecher, H. W., R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins. 1992. A C-terminal α-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
59. Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376:88-91.
60. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:2575-2586.
61. Waterman, J., J. Shenk, and T. Halazonetis. 1995. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14:512-519.
62. Waterman, M., J. Waterman, and T. Halazonetis. 1996. An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants. Cancer Res. 56:158-163.
63. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
64. Yang, X., V. Ogryzko, J. Nishikawa, B. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral E1A oncoprotein. Nature 382:319-324.
65. Yuan, W., G. Condorelli, M. Caruso, A. Felsani, and A. Giordano. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9003-9013.
66. Zhang, J., U. Vinkemeier, W. Gu, D. Chakravarti, C. Horvath, and J. J. Darnell. 1996. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93:15092-15096.